Close Menu


NEW YORK (360Dx) – Opko reported after the close of the market on Thursday that its fourth quarter revenues decreased 30 percent year over year.

 For the three months ended Dec. 31, 2017, total revenues came in a $193.7 million, compared to $275.5 million for the same quarter last year, and well short of the consensus Wall Street estimate of $301.4 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Sponsored by

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.